Literature DB >> 27989761

Anti-endothelial cell antibodies in vasculitis: A systematic review.

Paul Legendre1, Alexis Régent1, Mathilde Thiebault1, Luc Mouthon2.   

Abstract

Anti-endothelial cell antibodies (AECAs) are those that can bind to endothelial cells (ECs) via variable region-specific interactions. The identification and quantification of AECAs varies depending on the technique used. The best approach would be to combine at least two different methods. Thus, AECA measurement cannot be considered a diagnostic tool, but the detection and titers of AECAs are associated with disease activity in various systemic vasculitis diseases. AECAs have been described in almost all primary systemic vasculitis diseases but also in many secondary vasculitis diseases, with the identification of various antigens. AECAs may play a pathogenic role in vasculitis, both in vitro and in vivo, mainly via EC activation and induction of apoptosis. We used a systematic review of the literature to better define the prevalence, clinical association, targeted antigens, possible pathophysiologic role and clinical usefulness of AECAs in various types of vasculitis.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ANCA; Anti-endothelial cell antibodies; Giant cell arteritis; Vasculitis

Mesh:

Substances:

Year:  2016        PMID: 27989761     DOI: 10.1016/j.autrev.2016.12.012

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  14 in total

1.  Antibody-induced vascular inflammation skews infiltrating macrophages to a novel remodeling phenotype in a model of transplant rejection.

Authors:  Xuedong Wei; Nicole M Valenzuela; Maura Rossetti; Rebecca A Sosa; Jessica Nevarez-Mejia; Gregory A Fishbein; Arend Mulder; Jayeeta Dhar; Karen S Keslar; William M Baldwin; Robert L Fairchild; Jianquan Hou; Elaine F Reed
Journal:  Am J Transplant       Date:  2020-05-22       Impact factor: 8.086

Review 2.  Autoimmunity in 2017.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2018-12       Impact factor: 8.667

Review 3.  Autoimmunity in 2016.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2017-08       Impact factor: 8.667

Review 4.  IgA vasculitis nephritis in children and adults: one or different entities?

Authors:  Licia Peruzzi; Rosanna Coppo
Journal:  Pediatr Nephrol       Date:  2020-11-20       Impact factor: 3.714

Review 5.  Takayasu arteritis - epidemiology, pathogenesis, diagnosis and treatment.

Authors:  Dominika Podgorska; Rafal Podgorski; David Aebisher; Piotr Dabrowski
Journal:  J Appl Biomed       Date:  2019-01-09       Impact factor: 1.797

6.  Protein-bounded uremic toxin p-cresylsulfate induces vascular permeability alternations.

Authors:  Wei-Hua Tang; Chao-Ping Wang; Teng-Hung Yu; Pei-Yang Tai; Shih-Shin Liang; Wei-Chin Hung; Cheng-Ching Wu; Sung-Hao Huang; Yau-Jiunn Lee; Shih-Chieh Chen
Journal:  Histochem Cell Biol       Date:  2018-03-28       Impact factor: 4.304

7.  Anti-PD-1 Vasculitis of the central nervous system or radionecrosis?

Authors:  Roger Sun; Francois-Xavier Danlos; Samy Ammari; Guillaume Louvel; Frédéric Dhermain; Stéphane Champiat; Olivier Lambotte; Eric Deutsch
Journal:  J Immunother Cancer       Date:  2017-12-19       Impact factor: 13.751

Review 8.  How Should We Classify Kawasaki Disease?

Authors:  Edoardo Marrani; Jane C Burns; Rolando Cimaz
Journal:  Front Immunol       Date:  2018-12-14       Impact factor: 7.561

9.  Optic Neuropathy Secondary to Polyarteritis Nodosa, Case Report, and Diagnostic Challenges.

Authors:  Kristian A Vazquez-Romo; Adrian Rodriguez-Hernandez; Jose A Paczka; Moises A Nuño-Suarez; Alberto D Rocha-Muñoz; Maria G Zavala-Cerna
Journal:  Front Neurol       Date:  2017-09-20       Impact factor: 4.003

10.  Cerebral microvascular and microstructural integrity is regionally altered in patients with systemic lupus erythematosus.

Authors:  Mark W DiFrancesco; Gregory Lee; Mekibib Altaye; Dean W Beebe; Jamie Meyers-Eaton; Hermine I Brunner
Journal:  Arthritis Res Ther       Date:  2020-06-08       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.